Fundraising Fox

R42 GroupFull Portfolio

4 tracked investments · listed companies and verified rows first

Bounce Imagingbounceimaging.comin𝕏May 2022 · $4.2M

Bounce Imaging manufactures tactical 360-degree camera systems and robotics for first responders, law enforcement, and military personnel to safely assess confined spaces.

Defense TechHardwareRoboticsBuffalo, US

Francisco Aguilar(Executive Officer, Director)inRonjon Nag(Director)inJames Smist(Director)Sietse Dijkstra(Executive Officer)inMark Fargason(Executive Officer)inMikhail Fridberg(Executive Officer)in

Co-investorsIn-Q-TelBantam GroupBroad Street AngelsBrown and White VenturesDC Investment PartnersGood Growth Capital+4 more

Exogeneexogene.co.ukApr 2022

Exogene is a techbio startup using a generative AI and deep learning platform to discover novel, high-affinity TCR-based (T-cell receptor) therapies for treating solid tumors.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Federico Paoletti(CEO & Co-Founder)inAndrea Mambrini(CTO & Co-Founder)in

Co-investorsEntrepreneur FirstUnruly CapitalSelvedge Venture

Fountain Therapeuticsfountainml.cominNov 2021

Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates.

BiotechHealthtechLongevitySan Francisco, US

Thomas Rando(Co-founder)Joseph Rodgers(Co-founder)inTom Cheung(Co-founder)inTsang(Chief Business Officer)

Co-investorsAlexandriaKhosla VenturesNan Fung Life Sciences

Spireaspirea.co.ukinJun 2022 · $3M

Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases.

BiotechDeep TechHealthtech

Myriam Ouberai(Founder)inBo Rode Hansen(Executive Director)in

Co-investorsCambridge Angels groupStart CodonACF InvestorsO2h Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.